(5-bromopyridin-2-yl)-(4-chlorophenyl)methanone结构式
|
常用名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone | 英文名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone |
---|---|---|---|---|
CAS号 | 917899-52-6 | 分子量 | 296.54700 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C12H7BrClNO | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone |
---|---|
英文别名 | 更多 |
分子式 | C12H7BrClNO |
---|---|
分子量 | 296.54700 |
精确质量 | 294.94000 |
PSA | 29.96000 |
LogP | 3.72850 |
~32% (5-bromopyridin... 917899-52-6 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 208-209 ; WO 2006/136830 A1 |
(4-chloro-phenyl)-(5-bromo-pyridin-2-yl)-methanone |
Methanone,(5-bromo-2-pyridinyl)(4-chlorophenyl) |